Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

Signe Amalie Wolthers Laursen, Jakob Stenberg, Henning Morris Bay Nielsen, Jakob Stensballe, Henrik Planck Pedersen

Publikation: Bidrag til tidsskriftArtikelForskningpeer review


The COVID-19-pandemic has had a huge impact on health and economics all over the world resulting in widespread vaccine development. Vaccine-induced immune thrombotic thrombocytropenia has been described, suggesting a link between the two adeno-vector vaccines ChAdOx1 nCoV-19 (Vaxzevria from AstraZeneca) and Ad26.COV2-S (Janssen from Johnson and Johnson). This rare clinical condition should be suspected in patients with headache, abdominal pain, suspected thrombosis or hemorrhage and thrombocytopenia within 3-30-day post vaccine. In this case report a previously healthy man had thrombocytopenia with fatal intracerebral haemorrhage which was suspected to be related to vaccine.

Bidragets oversatte titel[Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19]
Sider (fra-til)1811-1812
Antal sider2
TidsskriftUgeskrift for Laeger
Udgave nummer19
StatusUdgivet - 30 aug. 2021


  • COVID-19
  • COVID-19 Vaccines
  • Cerebral Hemorrhage
  • Humans
  • Male
  • SARS-CoV-2
  • Vaccination


Udforsk hvilke forskningsemner 'Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19' indeholder.